Ga 101;Humab(cd20);Ro 5072759;Ro5072759;afutuzumab;Obinutuzumab/afutuzumab;Obinutuzumab;Research Grade Obinutuzumab(DHC90704)
用途
1. In combination with chlorambucil for the treatment of previously untreated chronic lymphocytic leukemia (CLL);
2. In combination with bendamustine for the treatment of relapsed or refractory follicular lymphoma (FL) in patients who have previously received rituximab therapy.